Compounded formulations are typically considered when brand-name supply is constrained or when a personalized dose is clinically indicated
However, you should contact your GP for persistent symptoms, NHS 111 for urgent concerns, or attend A&E if you experience severe, persistent vomiting, signs of dehydration (dark urine, dizziness, reduced urination), severe abdominal pain (especially if radiating to the back), or symptoms of gallbladder problems (severe upper right abdominal pain, fever, yellowing of skin/eyes)
In the phase 2b trial, however, the reductions in glycated hemoglobin and body weight in participants treated with NNC0090-2746 were similar to those in the group treated with liraglutide (76), and no phase 3 trial of NNC0090-2746 has been reported yet
Understanding the Link Between GLP-1 Agonists and Suicidal Ideation Current Evidence and Regulatory Guidance from MHRA and EMA Recognising Warning Signs and When to Seek Medical Help Safe Use of GLP-1 Agonists: What Patients Should Know Scientific References Frequently Asked Questions What Are GLP-1 Agonists and How Do They Work
One downside of Sofwave
